Instrument Inactif

Communiqués Sio Gene Therapies Deutsche Boerse AG

Actions

6YY

US8293991043

Communiqués

02/02/24	Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share	AQ
02/02/24	Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share	GL
06/04/23	SIO GENE THERAPIES INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
15/03/23	Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K	PU
15/03/23	SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
14/02/23	SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
14/12/22	Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution	GL
14/12/22	Sio Gene Therapies : Announces Board Approval of Plan of Complete Liquidation and Dissolution - Form 8-K	PU
14/12/22	SIO GENE THERAPIES INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
10/11/22	SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
10/11/22	Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial Results	AQ
14/09/22	Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K	PU
14/09/22	SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
11/08/22	Sio Gene Therapies : Announces Fiscal First Quarter 2022 Financial Results - Form 8-K	PU
11/08/22	SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
11/08/22	Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results	AQ
14/06/22	Sio Gene Therapies : Announces Fiscal Year 2021 Year-End Financial Results - Form 8-K	PU
14/06/22	SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
14/06/22	Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results	AQ
28/04/22	Sio Gene Therapies : Provides Corporate Update - Form 8-K	PU
27/04/22	SIO GENE THERAPIES INC. : Termination of a Material Definitive Agreement, Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
27/04/22	Sio Gene Therapies Provides Corporate Update	AQ
18/03/22	SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
14/02/22	Sio Gene Therapies Announces Corporate Updates and Fiscal Third Quarter 2021 Financial Results	AQ
11/02/22	Sio Gene Therapies : Announces Corporate Updates and Fiscal Third Quarter 2021 Financial Results - Form 8-K	PU